{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T19:14:22Z","timestamp":1697397262933},"reference-count":19,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2005,7,15]],"date-time":"2005-07-15T00:00:00Z","timestamp":1121385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p> <jats:italic>Hintergrund:<\/jats:italic> Im Vergleich zur alleinigen Vitalf\u00e4rbung der Lymphabflusswege bei der Sentinel\u2010Lymphknotendissektion hat die intraoperative Anwendung einer Gamma\u2010Detektionssonde die Identifikationsraten verbessert. In der vorliegenden retrospektiven Studie wird der Einfluss der Gamma\u2010Detektion hinsichtlich weiterer Aspekte ausf\u00fchrlich analysiert.<\/jats:p><jats:p> <jats:italic>Patienten und Methodik:<\/jats:italic> 81 Patienten, bei denen zur intraoperativen Detektion des Sentinel\u2010Lymphknotens (SLK) ausschlie\u00dflich Patentblau zum Einsatz kam, wurden mit 247 Patienten verglichen, bei denen zus\u00e4tzlich eine Gamma\u2010Sonde verwendet wurde.<\/jats:p><jats:p> <jats:italic>Ergebnisse:<\/jats:italic> Die Einf\u00fchrung der Gamma\u2010Sonde erbrachte eine Steigerung der SLK\u2010Detektionsrate von 87,7\u2003% auf 99,2\u2003% (P\u2005&lt;\u20050,00001). Die Zahl der exzidierten SLK erh\u00f6hte sich von 1,4\u2005\u00b1\u20050,9 auf 1,8\u2005\u00b1\u20050,09 (P\u2005&lt;\u20050,00001). Die \u201eklinische Falsch\u2010negativ\u2010Rate\u201d sank von 15,8\u2003% auf 9,6\u2003%. Die Positivit\u00e4tsrate der komplettierenden Lymphknotendissektion sank von 50\u2003% auf 26,6\u2003%. Die Gamma\u2010Sonden\u2010gesteuerte Pr\u00e4paration hatte weniger Serome zur Folge (5,1\u2003% versus 15\u2003%, P\u2005=\u20050,01). Die \u00dcberlebens\u2010 und Rezidivraten nach alleiniger Vitalf\u00e4rbung bzw. zus\u00e4tzlicher Gamma\u2010Detektion unterschieden sich nicht signifikant. Die Wahrscheinlichkeit, innerhalb von 5 Jahren ein Rezidiv im Lymphknotengebiet zu entwickeln war 7,9\u2003% nach negativer SLK\u2010Dissektion und 25,3\u2003% nach positiver SLK\u2010Dissektion mit anschlie\u00dfender komplettierender Lymphknotendissektion.<\/jats:p><jats:p> <jats:italic>Schlussfolgerungen:<\/jats:italic> Der kombinierte Einsatz von Vitalf\u00e4rbung und Gamma\u2010Sonde erh\u00f6hte die Sensitivit\u00e4t und senkte das Risiko der postoperativen Seromentwicklung, war aber ohne signifikanten Einfluss auf die Rezidiv\u2010 und \u00dcberlebensraten.<\/jats:p>","DOI":"10.1111\/j.1610-0387.2005.05735.x","type":"journal-article","created":{"date-parts":[[2005,7,15]],"date-time":"2005-07-15T17:24:49Z","timestamp":1121448289000},"page":"615-622","source":"Crossref","is-referenced-by-count":16,"title":["Intraoperative Detektion von Sentinel\u2010Lymphknoten beim malignen Melanom der Haut\u2010Vitalf\u00e4rbung allein versus Vitalf\u00e4rbung plus Gammasonde"],"prefix":"10.1111","volume":"3","author":[{"given":"Lutz","family":"Kretschmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai\u2010Martin","family":"Thoms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Mitteldorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Emmert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten\u2010Oliver","family":"Sahlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Peter","family":"Bertsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Meller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,7,15]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.16.3635"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000078580"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000086543.45557.cb"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2003.07.003"},{"key":"e_1_2_5_6_2","unstructured":"MunzDL AltmeyerP HolzmannH EnckeA HorG.[The place of lymphoscintigraphy in the treatment of malignant melanoma of the skin.]Dtsch Med Wochenschr1982;107:86\u200a\u2013\u200a91."},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1992.01420040034005"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-7404(06)80006-X"},{"key":"e_1_2_5_9_2","doi-asserted-by":"crossref","unstructured":"KretschmerL BertschHP MellerJ.[Sentinel lymphonodectomy in malignant melanoma\u2010an update.]JDDG2004;1:777\u200a\u2013\u200a784.","DOI":"10.1046\/j.1439-0353.2003.03048.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2004.04.004"},{"key":"e_1_2_5_11_2","doi-asserted-by":"crossref","unstructured":"Kretschmer L Beckmann I Thoms KM H. Haenssle Bertsch HP Neumann Ch. Sentinel lymphonodectomy does not increase the risk of locoregional cutaneous metastases of malignant melanomas. Eur J Cancer 2005; 41: 531\u200a\u2013\u200a538.","DOI":"10.1016\/j.ejca.2004.11.019"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10434-000-0469-z"},{"key":"e_1_2_5_13_2","doi-asserted-by":"crossref","unstructured":"CookMG GreenMA AndersonB EggermontAM RuiterDJ SpatzA KissinMW PowellBW EORTCMelanoma Group.The development of optimal pathological assessment of sentinel lymph nodes for melanoma.J Pathol.2003;200:314\u200a\u2013\u200a319.","DOI":"10.1002\/path.1365"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010601)91:11<2110::AID-CNCR1239>3.0.CO;2-Q"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/030089160008600401"},{"key":"e_1_2_5_16_2","doi-asserted-by":"crossref","unstructured":"EssnerR CochranAJ.Sentinel node biopsy: not only a staging tool? Recent ResultsCancer Res.2002;160:133\u200a\u2013\u200a148.","DOI":"10.1007\/978-3-642-59410-6_17"},{"key":"e_1_2_5_17_2","doi-asserted-by":"crossref","unstructured":"PorterGA RossMI BermanRS SumnerWE 3rd LeeJE MansfieldPF GershenwaldJE.How many lymph nodes are enough during sentinel lymphadenectomy for primary melanoma?Surgery.2000;128:306\u200a\u2013\u200a311.","DOI":"10.1067\/msy.2000.107418"},{"key":"e_1_2_5_18_2","doi-asserted-by":"crossref","unstructured":"WohrlS FockeM HinterhuberG StinglG BinderM.Near\u2010fatal anaphylaxis to patent blue V.Br J Dermatol.2004;150:1037\u200a\u2013\u200a1038.","DOI":"10.1111\/j.1365-2133.2004.05931.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"crossref","unstructured":"Harlow SP Krag DN Ashikaga T Weaver DL Meijer SJ Loggie BW Tanabe KK Whitworth P Jr Kuhn J Kusminsky R Carp NZ Gadd M Rawlings M Jr Slingluff CL Jr. Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre study. Melanoma Res 2001; 11: 45\u200a\u2013\u200a55.","DOI":"10.1097\/00008390-200102000-00006"},{"key":"e_1_2_5_20_2","doi-asserted-by":"crossref","unstructured":"Oliveira Filho RS Santos ID Ferreira LM de Almeida FA Simoes e Silvia Enokihara MM Barbieri A Tovo Filho R. Is intra\u2010operative gamma probe detection really necessary for inguinal sentinel lymph node biopsy? Sao Paulo Med J. 2000; 118: 165\u200a\u2013\u200a168.","DOI":"10.1590\/S1516-31802000000600003"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1610-0387.2005.05735.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1610-0387.2005.05735.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T01:06:47Z","timestamp":1697072807000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1610-0387.2005.05735.x"}},"subtitle":["Intraoperative detection of sentinel lymph nodes in cutaneous malignant melanoma \u2013 blue dye alone versus blue dye plus gamma\u2010detection"],"short-title":[],"issued":{"date-parts":[[2005,7,15]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1111\/j.1610-0387.2005.05735.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1610-0387.2005.05735.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,15]]}}}